With the advent of advanced technologies like machine learning, artificial intelligence, and Internet of things in Canada, the Canada telemedicine market is expected to grow from $4.86 Bn in 2022 to $18.53 Bn in 2030 with a CAGR of 18.2% for year 2022-2030. The market is segmented by products and services, end user, and by delivery mode.
The legalization of medical cannabis in Canada has resulted in the growth of Canada cannabis for GI diseases market. Cannabis can be used to treat irritable bowel disease, inflammatory bowel diseases, and colitis. The market is segmented by application and by product type.
Canada dermatology market is projected to grow from $2.78 Bn in 2022 to $5.31 Bn in 2030 with a CAGR of 8.44% for the year 2022-2030. More Canadians investing in skincare solutions is driving the Canada dermatology market. Major dermatological disorders in Canada are alopecia and psoriasis.
The Canada pharmacy market is expected to witness growth from $83.08 Bn in 2022 to $141.69 Bn in 2030 with a CAGR of 6.9% for the year 2022-2030. Major market drivers include increasing health expenditure and a rise in per capita disposable income. The market is segmented by industry products and services and by pharmacy groups.
The market size of Canada OTC market was valued at $13.62 Bn in 2022 to $23.58 Bn in 2030 with a CAGR of 7.1% for the year 2022-2030. The Canada OTC market is segmented by drug type and by distribution channel. Johnson and Johnson and Pfizer are some of the key players in the market.
The Canada digital health market is projected to grow from $16.88 Bn in 2022 to $66.07 Bn in 2030 with a CAGR of 18.6% for the year 2022-2030. Many companies in Canada are entering into a digital pace focussed on providing accessibility, quality, and efficient treatments in Canada. The market is segmented by technology, end users and components.
The Canada clinical diagnostics market is projected to witness growth from $3.9 Bn in 2022 to $4.9 Bn in 2030 with a CAGR of 3.1% for the year 2022-2030. Growing awareness about early detection and treatment planning are the major growth drivers for the market. The market is segmented by molecular diagnostics and by the end user.
The Canada dermatology prescription market is projected to grow from $459.7 Mn in 2022 to $927.4 Mn in 2030 with a CAGR of 9.2% for the year 2022-2030. Technological advancements and a strong pipeline of drugs are the possible market drivers for the growth of the market during the forecast period.